Statistics for Celldex Therapeutics (id:5262 CLDX)

Valuation metrics

Market cap

1.79B

Enterprise value

986.63M

Trailing P/E (ttm)

-9.25

Forward P/E

-8.37

PEG ratio

-8.37

Price/Sales (ttm)

179.69

Price/Book (mrq)

2.28

Enterprise Value/Revenue

98.90

Enterprise Value/EBITDA

-5.77

Overview

Shares outstanding

66.34M

Float

66.16M

Shares short

8.24M

% Held by insiders

0.00%

% Held by institutions

1.10%

Average volume (10 days)

953.13K

Average volume (90 days)

Price summary

52-Week low

22.93

52-Week high

53.18

52-Week change

-6.11%

Beta

1.59

50-Day moving average

30.56

200-Day moving average

36.87

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

February 11th, 2019

Ex-dividend date

Last split factor

2:1

Last split date

February 11th, 2019

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,633.53%

Operational effectiveness

Return on assets

-19.73%

Return on equity

-29.84%

Income statement

Revenue (ttm)

0.16

Revenue per share (ttm)

0.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-171,060,992.00

Net income to common (ttm)

-154,076,992.00

Diluted EPS (ttm)

-2.58

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

756.00M

Total cash per share (mrq)

11.40

Total debt (mrq)

3.09M

Total Debt/Equity (mrq)

0.39

Current ratio (mrq)

2.43K%

Book value per share (mrq)

11.85

Cash flow

Cash flow statement

-157,835,008.00

Levered free cash flow (LFCF)

-83,732,248.00